Flamel Technologies Launches Akovaz(TM)
LYON, FRANCE--(Healthcare Sales & Marketing Network) - Flamel Technologies ( NASDAQ : FLML ) today announced the launch of Akovaz, its formulation of ephedrine sulfate for injection, which received approval from the U.S. Food and Drug Administration (FDA)... Biopharmaceuticals, Drug Delivery, Product Launch Flamel Technologies, Akovaz, ephedrine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news